Medically reviewed by Susan Bard, MD Atopic dermatitis, a type of eczema, causes dry, itchy, and inflamed skin. After a flare ...

Atopic dermatitis, also known as eczema, is more than just dry, itchy skin—it can affect your daily life in ways you may not ...

Alexis Smith uses her eczema to teach others about the condition, which has helped booster her confidence over time.

A phase 3 trial shows that ivarmacitinib improves symptoms in adults with moderate to severe atopic dermatitis compared with ...

Patients with early-onset atopic dermatitis, especially those with severe atopic dermatitis, are more likely to develop pediatric uveitis.

Raelle Kennedy spent years managing the skin manifestations of her eczema. Topical steroid withdrawal urged her to get at the ...

Allergies are among the most common health issues affecting people worldwide, often leading to symptoms such as sneezing, itching, rashes, and breathing difficulties. At the core of most allergic ...

Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria Approval based on phase 3 studies demonstrating Dupixent significantly reduced itch and ...

Textiles and other materials worth millions of naira were lost in a fire at the popular Bola Ige Market in Gbagi, located in the Egbeda local government area, on Sunday. The incident, which ...

(NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has approved Dupixent ® (dupilumab) for the treatment of adults and adolescents aged 12 years and older with ...

Getty Images Clinical phenotypes of atopic dermatitis can vary greatly based on skin color and can make atopic dermatitis difficult to diagnose. Recognizing the clinical diversity of presentation ...

Study B (n=108) provided additional safety data and evaluated Dupixent in patients aged 12 years and older who were inadequate responders or intolerant to anti-IgE therapy and symptomatic ... such as ...